Vera Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:VERA  
17.00
+0.42 (+2.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Vera Therapeutics Inc - Ordinary Shares - Class A Stock, NASDAQ:VERA

170 Harbor Way, 3rd floor, South San Francisco, California 94080
United States of America
Phone: +1.650.770.0077
Number of Employees: 29

Description

Vera Therapeutics, Inc. is a clinical stage biotechnical company that engages in the development and commercialization of transformative treatments for immunological diseases. Its primary product, atacicept, is a fusion protein self-administered as a subcutaneous injection that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in South San Francisco, CA.